Literature DB >> 22847213

Dietary selenium and selenoprotein function.

Benjamin S Weeks1, Mirna S Hanna, Deborah Cooperstein.   

Abstract

Selenium is a trace mineral and an essential nutrient in the human diet. Selenium is found in soil and water and consequently enters the food chain through the root ways of plants and aquatic organisms. Some areas of the world are low in soil selenium resulting in a selenium deficient population and the appearance of an associated heart disease and bone disorders that can be corrected with dietary selenium. Indeed the requirement for dietary selenium was established by these observations and while selenium deficiency is rare in the West, patients requiring long-term intravenous feedings have also show heart disease associated with a deficiency of selenium in the feeding fluids. Subsequently, it has been established that dietary selenium can improve a wide range of human health conditions even in areas with soil replete in selenium.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22847213      PMCID: PMC3560698          DOI: 10.12659/msm.883258

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


Background

Dietary selenium (Se) functions and mediates health benefits through incorporation into cysteine (MeCyst) prior to protein synthesis forming the 21st amino acid used during protein synthesis (ref). Proteins into which MeCyst is incorporated are known as “selenoproteins” and require dietary selenium to be fully functional. Selenoproteins fulfill vital functions in the body. For example, selenoproteins are: a) essential antioxidant enzymes that fight cancer and other chemical toxicities, b) regulators of thyroid hormone and thyroid function, c) structural proteins in sperm required for fertility, and d) can reduce the virulence associated with certain viral infections including HIV-1. Because the value of Se can only be understood through the activity of selenoproteins, this review takes the unique and challenging approach of presenting the nutritional benefits of selenium by listing and linking selenoprotein function to evidence of health benefits. Table 1 shows a list of the known human selenoproteins and their known roles in human health.
Table 1

A list of selenoproteins and the health benefit suggested through either cell culture studies, animal studies or human clinical trials.

SelenoproteinSuggested Health Benefit by Study DesignReference
GPx1Antioxidant
Cell Culture Studies
Protects human cells from UV-induced DNA damage19
Animal Studies
Protects mice from colon cancer20
Protects rodents from chemical toxicity24,25
Protects mice from viral associated cardiomyopathy26
Human Clinical Trials
Protects stressed neurons in Parkinson’s Disease23
GPx2Antioxidant
Cell Culture Studies
Reduces metastatic properties of human cancer cells5
Animal Studies
Protects mice from intestinal cancer4
GPx3Antioxidant
Human Clinical Trials
Protects people from cerebral clots and stroke3942
Protects people from atherosclerosis and cardiovascular disease4345
GPx4Antioxidant
Animal Studies
Protects mice from Parkinson’s-like neurodegeneration2931
Supports normal brain development in mice3234
Prevents developmental neurological defects in mice48,49
Human Clinical Trials
Vital for sperm production, motility and fertility in men46,47
TR1Antioxidant
Cell Culture Studies
Inhibits HIV replication in human macrophages60
Animal Studies
Required for live birth in mice50
TR2Antioxidant
Animal Studies
Required for live birth in mice50
D2Thyroid Function
Animal Studies
Maintains healthy metabolic rate in mice54, 55
Sel NAntioxidant
Animal Studies
Supports normal muscle development in mice51
Sel PAntioxidant
Animal Studies
Prevents neurodegeneration35
Prevents infertility in mice58
Human Clinical Trials
Prevents cancers in humans6, 7
Protects humans from Alzheimer’s Disease38
Sel TUnknown
Cell Culture Studies
Supports neurite/nerve formation in rodent neuronal cells52
SPS2Synthesis of all other selenoproteins
Human Clinical Trials
Maintains healthy metabolic rate in humans33
It is important to note that understanding selenoprotein functions overlaps with nutritional studies, but does not nearly account for all of the dietary clinical studies that show general health improvements with increased oral selenium intake. Therefore this review will also present most of the recent clinical studies in which selenium was shown to benefit human health. In specific, increased dietary intake of selenium has also been shown to: a) reduce cancer incidence, b) reduce cancer-associated mortality, c) reduce oxidative damage and poisoning associated with chemo- and radiotherapy, d) reduce severity of autoimmune diseases, e) improve mental health, f) improve reproductive performance, g) improve elderly thymus and thyroid function and h) provide various additional health benefits including a slowed progression from HIV-1 infection to AIDS (Table 1).

Selenoprotein Functions

Antioxidant enzymes: Prevention of cancer, toxicities, neurodegeneration, atherosclerosis and stroke

Antioxidant enzymes are required for elimination toxins known as reactive oxygen species (ROS). ROS toxins form naturally in our cells simply from oxygen metabolism and can also form as a result of exposure to chemical pollutants and drugs. These ROS toxins cause damage to DNA, cell membranes, and a variety of other cell structures and leads to “oxidative stress”. We take antioxidants to mitigate the effects of oxidative stress. If we do not have enough antioxidant capacity, oxidative stress can lead to cell death, organ system failure, cancer, inflammatory disease, cardiovascular disease, poor wound healing, hearing impairment and stroke. Selenoproteins constitute one of the most important classes of antioxidant enzymes the glutathione peroxidases (GPx). In the human body there are eight forms of GPxs (GPx1GPx8) and of these, five (GPx1GPx4, and GPx6) are selenoproteins [1]. In addition to these well studies antioxidant enzyme systems, at least seven additional selenoproteins (TR1, TR2, TR3, Sel P, Sel R and Sel W) have been suggested to play a role in humans in protecting against oxidative stress and the elimination of ROS toxins. For example, UV light and the gentotoxic carcinogen azoxymethane are both know to elevate cellular ROS toxins and cause cancer. In studies using in vitro cultures of human breast cancer cells, both the addition of selenium to the culture medium and enhanced expression of GPx1 protected these cells from UV induced DNA damage [2]. Further, mice engineered to lack GPx1 (GPx1 knockouts) were more susceptible to colon abnormalities when treated with the colonic carcinogen, azoxymethane, [3]. GPx2 is primarily express in the gut epithelium and mice engineered to lack GPx2 (GPx2 knockouts) have an increase incidence of intestinal cancer [4]. Further, in vitro cultures of human cancer cells in which production of GPx2 was blocked demonstrated an increase in invasive and migratory properties associated with metastatic potential [5]. In human studies, increased risks for prostate cancer and lung cancer (non-small cell lung carcinoma) have been associated with low Sel P production [6,7]. These studies support the observation that selenium deficient diets may put people at risk for developing cancer and that increasing selenium intake may boost the antioxidant capabilities of selenoproteins in cancer therapy and prevention. In addition to being more susceptible to DNA damage and cancer, GPX1 knockout mice demonstrate increase rates of sickness and death when exposed to ROS-inducing chemicals such as paraquat [8,9] and also to coxsackievirus-associated cardiac disease [10]. Further, GPx1 may protect the central nervous system from ROS induced neurodegeneration. Microglia and astrocytes protect neurons in the brain from oxidative stress (ROS-induced damage). Studies in rodents have shown that microglia and astrocytes express high levels of GPx1 in rodents [11,12] and humans with Parkinson’s and dementia show microglia with elevated GPx1 activity associated with distressed neurons [13]. GPx4 depletion in the hippocampus of mice has been shown to cause oxidative-damage in brain neurons leading to cell death like that seen in Parkinson’s Disease and b-amyloid production like that seen in Alzheimer’s Disease [14-16]. In addition to preventing neurodegenerative diseases in adults, GPx4 antioxidant activity also supports normal brain development in mice [17-19]. Knockout of the selenoprotein, Sel P, in mice also leads to neurodegeneration [20]. Moreover, elevated Sel P is found in post-mortem analysis of b-amyloid plaques of Alzheimers Disease patients [21] further suggesting a role for oxidative stress in neurodegenerative diseases and the potential for selenium and selenoproteins to prevent their onset. Selenoproteins are also important for cardiovascular health. Human clinical studies also show that people with low Gpx3 activity have reduced capacity to metabolize ROS toxins and consequently present with increase risk for both arterial and cerebral clots and stroke [22-25]. Further, in a mouse model of atherosclerosis, over-expression of GPx4 leads to reduced lipid peroxidation and associated atherosclerotic plaque [26]. People with specific genetic variants of the selenoprotein, Sel S have also been shown to be at a higher risk for cardiovascular disease and stroke although this increased risk has not been associated with ROS metabolism [27,28].

Thyroid Function

In addition to serving as antioxidant enzymes, selenoproteins are essential to thyroid gland function. The thyroid gland produces thyroid hormone which in turn regulates a variety of metabolic events in humans. Thyroid hormone formation requires selenoproteins and selenoproteins can also regulate thyroid hormone activity by inactivating it. These selenoproteins are the deiodinases enzymes, D1, D2 and D3. The conversion of the thyroid hormone precursor, T4, to the active T3 hormone is mediated by D1 or D2 while both D1 and D3 can inactivate T3 [29]. Mice genetically lacking the D2 selenoprotein exhibit reduced thyroid stimulating hormone regulation and reduced capacity to metabolize fat to keep warm (brown fat thermogenesis) [30,31]. Interestingly the thyroid expresses as many as 11 different selenoproteins to protect this gland from the oxidative stress high levels of ROS hydrogen peroxide which is a byproduct of thyroid hormone synthesis [32]. Indeed, people with mutations in the a gene that encodes for a selenoprotein synthesis factor suffer with thyroid function defects [33].

Fertility

While the two clear categories of selenoprotein activity are antioxidant protection from ROS metabolites and thyroid hormone function, selenoproteins play several diverse important structural and functional roles in cell physiology that are important to human health. GPx4 is an important structural protein of sperm and low sperm GPx activity is associated with reduced viability and motility in men [34,35]. Mice lacking the seloprotein Sel P gene exhibit male infertility [36]. Further, developing mouse embryos that lack GPx4 die in mid gestation from developmental neurological defects [37,38]. Genetic deletion of TR1 and TR2 leads to embryonic lethality in mice [39] and and depletion of the selenoprotein, Sel N leads to muscle malformation in zebrafish embryos [40]. Sel T expression is increased during neurite formation in neuronal cell cultures [41] suggesting a role for this selenoprotein in neuronal development.

Viral Infections

In both mice and humans, reduced activity of GPx as a consequence of selenium deficiency leads to a more virulent coxakie viral infection and heart disease (Keshan Disease) [42-44]. Further, the level of the selenoprotein TR1 is found to be reduced in HIV-1 infected individuals [45]. Further, TR1 inhibits HIV-1 protein Tat which is responsible for transcriptional activity of the virus [46] and selenium deficiency has been associated with a more rapid progression from HIV infection to AIDS [47-49]. In HIV-1 infected patients on anti-retroviral therapy (ART), daily intake of 200 μg selenium increased circulating CD4+ T-cell levels by two to three fold compared to those on ART alone (50).

Clinical Studies with Dietary Selenium

Cancer

In 1996, in randomized clinical studies, the Nutritional Prevention Cancer Study Group reported in the Journal of the American Medical Association that selenium supplementation at 200 micrograms per day reduces the incidence and morbidity from basal and squamous cell carcinomas [51]. Subsequent randomized double blind studies confirmed these observations in 1997 [52] and were extended in placebo controlled studies to include prostate cancer in 1998 [53]. In 2002, randomized clinical trial known at the “Nutritional Prevention of Cancer Trial” was initiated as a multi-institutional investigation and showed that dietary selenium at 200 micrograms per day can reduce the risk of several site specific cancers [54]. By 2003 the Nutritional Prevention of Cancer Trial (NPCT) concluded that selenium supplementation can reduce the incidence of lung cancer in people with selenium deficiency and in blind, placebo controlled trials decreases prostate cancer incidence in selenium-replete patients with low prostate serum markers (PSA) [55]. Further analysis of the NPCT data revealed a reduced risk for colon cancer in patients with low blood selenium levels and also a beneficial effect particularly for smokers [56]. In 2009, a double blind, placebo controlled, prospective study demonstrated that women carrying BRCA1 gene mutations and a predisposition for breast cancer show a reduced risk when taking daily selenium supplements [57]. Most recently, a six month double blind placebo controlled study demonstrated that when taken in combination with silymarin, a milk thistle flavonolignan, selenium reduces the stage progression of prostate cancers [58]. In addition to directly reducing cancer incidences, cancer progression and mortality, dietary selenium has also been shown to alleviate some of the oxidative toxicities associated with cervical, ovarian, head and neck cancer chemo- and radiotherapies [59-62] and also improves the overall nutritional balance in these patients [63].

Immune system

Intake of high levels of selenium protects patients from inflammatory damage associated with sepsis and from rheumatoid arthritis [64,65]. Further, clinical trials show that increased dietary selenium can reduce autoantibody production in autoimmune thyroiditis, Grave’s disease and Psoriasis [66-68].

Reproductive health

Intravenous selenium administration improves the outcomes for preterm infants born in selenium-deficient areas [69,70]. Placebo controlled clinical trials also increase the fertility of men living in low selenium areas leading to successful conception [71]. Dietary selenium also reduces pre-labor membrane rupture and preeclampsia [72,73].

Mental health

Several clinical studies have shown that dietary selenium can improve mood by reducing anxiety and depression [74,75] including post-partum depression [76].

Conclusions

It is clear that selenium is a required dietary nutrient. Selenium is unique in its structural incorporation into proteins (selenoproteins) which in functioning as antioxidants, regulators of thyroid function, and structural proteins, serve to prevent cancer, improve cardiovascular health, prevent stroke and atherosclerosis, prevent neurodegeneration, promote healthy embryonic nervous system and muscle development, improve fertility and the immune response and fight viral infections including HIV-1 (Table 1). Dietary selenium can enhance selenoprotein activity and reduce the risk of various cancers, thyroid disorders, drug toxicities and autoimmune diseases and improve mental health, reproductive outcomes and possibly fight AIDS (Table 1).
  72 in total

Review 1.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.

Authors:  Antonio C Bianco; Domenico Salvatore; Balázs Gereben; Marla J Berry; P Reed Larsen
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

2.  Selenium substitution during radiotherapy of solid tumours - laboratory data from two observation studies in gynaecological and head and neck cancer patients.

Authors:  Jens Büntzel; Oliver Micke; Klaus Kisters; Frank Bruns; Michael Glatzel; Klaus Schönekaes; Günther Kundt; Ulrich Schäfer; Ralph Mücke
Journal:  Anticancer Res       Date:  2010-05       Impact factor: 2.480

3.  Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4.

Authors:  M J Schneider; S N Fiering; S E Pallud; A F Parlow; D L St Germain; V A Galton
Journal:  Mol Endocrinol       Date:  2001-12

4.  Selenium supplementation and premature (pre-labour) rupture of membranes: a randomised double-blind placebo-controlled trial.

Authors:  F Tara; M P Rayman; H Boskabadi; M Ghayour-Mobarhan; A Sahebkar; O Yazarlu; S Ouladan; S Tavallaie; M Azimi-Nezhad; M T Shakeri; M S Teymoori; B S Razavi; M Oladi; G Ferns
Journal:  J Obstet Gynaecol       Date:  2010-01       Impact factor: 1.246

5.  Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.

Authors:  Matthew L Cooper; Hans-Olov Adami; Henrik Grönberg; Fredrik Wiklund; Fiona R Green; Margaret P Rayman
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

6.  Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies.

Authors:  John H T Power; Peter C Blumbergs
Journal:  Acta Neuropathol       Date:  2008-10-14       Impact factor: 17.088

7.  Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer.

Authors:  Peter Gresner; Jolanta Gromadzinska; Ewa Jablonska; Jacek Kaczmarski; Wojciech Wasowicz
Journal:  Lung Cancer       Date:  2008-12-06       Impact factor: 5.705

8.  Glutathione Peroxidase 2 Inhibits Cyclooxygenase-2-Mediated Migration and Invasion of HT-29 Adenocarcinoma Cells but Supports Their Growth as Tumors in Nude Mice.

Authors:  Antje Banning; Anna Kipp; Stephanie Schmitmeier; Maria Löwinger; Simone Florian; Susanne Krehl; Sophie Thalmann; René Thierbach; Pablo Steinberg; Regina Brigelius-Flohé
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

9.  Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers.

Authors:  Tomasz Dziaman; Tomasz Huzarski; Daniel Gackowski; Rafal Rozalski; Agnieszka Siomek; Anna Szpila; Jolanta Guz; Jan Lubinski; Wojciech Wasowicz; Krzysztof Roszkowski; Ryszard Olinski
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

10.  Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease.

Authors:  Jeff Blackinton; Ravindran Kumaran; Marcel P van der Brug; Rili Ahmad; Lars Olson; Dagmar Galter; Andrew Lees; Rina Bandopadhyay; Mark R Cookson
Journal:  Neurosci Lett       Date:  2009-01-06       Impact factor: 3.046

View more
  9 in total

1.  Simultaneous occurrence of metabolic, hematologic, neurologic and cardiac complications after Roux-en-Y gastric bypass for morbid obesity.

Authors:  Merve Kara; Yasemin Gundogdu; Merve Karsli; Volkan Ozben; Fatih Oguz Onder; Bilgi Baca
Journal:  Clin J Gastroenterol       Date:  2016-08-04

2.  Assessment of selenium toxicity on the life cycle of Caenorhabditis elegans.

Authors:  Wen-Hsuan Li; Yun-Ru Ju; Chung-Min Liao; Vivian Hsiu-Chuan Liao
Journal:  Ecotoxicology       Date:  2014-06-07       Impact factor: 2.823

Review 3.  Selenium supplementation in thyroid associated ophthalmopathy: an update.

Authors:  Aruna Dharmasena
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

4.  Selenoprotein S is involved in maintenance and transport of multiprotein complexes.

Authors:  Anton A Turanov; Valentina A Shchedrina; Robert A Everley; Alexei V Lobanov; Sun Hee Yim; Stefano M Marino; Steven P Gygi; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Biochem J       Date:  2014-09-15       Impact factor: 3.857

Review 5.  The intricate role of selenium and selenoproteins in erythropoiesis.

Authors:  Chang Liao; Bradley A Carlson; Robert F Paulson; K Sandeep Prabhu
Journal:  Free Radic Biol Med       Date:  2018-04-30       Impact factor: 7.376

6.  Skin changes after bariatric surgery.

Authors:  Ana Paula Dornelles da Silva Manzoni; Magda Blessmann Weber
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

Review 7.  Role of Selenoprotein F in Protein Folding and Secretion: Potential Involvement in Human Disease.

Authors:  Bingyu Ren; Min Liu; Jiazuan Ni; Jing Tian
Journal:  Nutrients       Date:  2018-11-02       Impact factor: 5.717

Review 8.  The Role of Selenium in Arsenic and Cadmium Toxicity: an Updated Review of Scientific Literature.

Authors:  Iwona Zwolak
Journal:  Biol Trace Elem Res       Date:  2019-03-15       Impact factor: 3.738

9.  Mitochondrial Protein Profile in Mice with Low or Excessive Selenium Diets.

Authors:  Lianmei Hu; Congcong Wang; Qin Zhang; Hao Yan; Ying Li; Jiaqiang Pan; Zhaoxin Tang
Journal:  Int J Mol Sci       Date:  2016-07-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.